RVPNYSESurgical & Medical Instruments & ApparatusFiscal year ends December 31
RETRACTABLE TECHNOLOGIES INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$0.58+0.00 (+0.33%)
Close on Oct 19, 2026
- Market cap
- $17.30M
- P/E (TTM)
- –
- Dividend yield
- –
RETRACTABLE TECHNOLOGIES INC revenue by segment
By business segment
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Single reportable segment | $33.90M | $37.15M | $38.27M | $37.90M | $38.16M | $33.75M | $33.05M | – | – | – | – | – | 100.0% | -11.2% |
| Other international sales | – | – | – | – | – | – | – | – | – | – | $2.91M | $2.06M | – | – |
| North and South America sales (excluding U.S.) | – | – | – | – | – | – | – | – | – | – | $6.09M | $10.29M | – | – |
| U.S. sales (excluding U.S. government) | – | – | – | – | – | – | – | – | – | – | $34.60M | $29.64M | – | – |
By product or service
| Revenue | TTM Q2 26 | TTM Q1 26 | TTM Q4 25 | TTM Q3 25 | TTM Q2 25 | TTM Q1 25 | TTM Q4 24 | TTM Q3 24 | TTM Q2 24 | TTM Q1 24 | TTM Q4 23 | TTM Q3 23 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Syringes | $24.07M | $23.75M | $24.91M | $24.42M | $23.75M | $23.31M | $22.63M | $27.62M | $29.80M | $30.67M | $34.16M | $35.53M | 71.0% | +1.4% |
| EasyPoint Needles | $8.40M | $11.95M | $11.94M | $12.13M | $13.14M | $9.13M | $8.95M | $8.88M | $6.59M | $7.65M | $7.25M | $4.40M | 24.8% | -36.0% |
| Blood Collection Products | $1.39M | $1.40M | $1.37M | $1.30M | $1.23M | $1.26M | $1.43M | $1.72M | $1.81M | $1.83M | $1.93M | $1.63M | 4.1% | +13.6% |
| Other Products | $31.51K | $42.93K | $43.63K | $47.34K | $47.30K | $45.56K | $45.85K | $45.53K | $56.74K | $52.71K | $266.27K | $436.95K | 0.1% | -33.4% |
| Licensing fees | $0 | $0 | $0 | – | – | – | – | $1.01M | $967.00K | $877.00K | $778.00K | – | 0.0% | – |
By region
From the segment and revenue-disaggregation notes of Retractable Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.